Document Detail


Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
MedLine Citation:
PMID:  8093548     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the tremolytic effect of long-acting propranolol (propranolol-LA) in six subjects with drug-induced parkinsonism (DIP), using a double-blind, placebo-controlled, crossover experimental design. Subjects received propranolol-LA for 2 weeks and placebo for 2 weeks, with no change in neuroleptic treatment. Tremor frequency and amplitude were objectively quantified at the end of each 2-week period by computerized tremorgram recording. There were no significant differences in attenuation of DIP tremor by propranolol-LA and placebo. Previous investigations reported in the literature have found propranolol to attenuate the tremor of idiopathic parkinsonism (IPD). It is expected that DIP and IPD tremor would respond similarly to propranolol if a solely peripheral or spinal cord tremolytic action were operative. A possible differential attenuation of IPD tremor and DIP tremor provides support for the concept of a higher central tremolytic mechanism of beta-adrenergic receptor-blocking drugs.
Authors:
W S Metzer; S R Paige; J E Newton
Related Documents :
15827998 - Reducing exposure of clinical research subjects to placebo treatments.
236528 - A double blind trial of nitrazepam and flurazepam as sedatives.
19534018 - Ramelteon: new drug. insomnia: no role for risky placebos.
2652018 - Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-...
23066958 - β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across t...
20709388 - Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Movement disorders : official journal of the Movement Disorder Society     Volume:  8     ISSN:  0885-3185     ISO Abbreviation:  Mov. Disord.     Publication Date:  1993  
Date Detail:
Created Date:  1993-02-11     Completed Date:  1993-02-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8610688     Medline TA:  Mov Disord     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  43-6     Citation Subset:  IM    
Affiliation:
Department of Neurology, University of Arkansas for Medical Science, Little Rock.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antipsychotic Agents / adverse effects*,  therapeutic use
Chronic Disease
Double-Blind Method
Drug Therapy, Combination
Dyskinesia, Drug-Induced / drug therapy*
Fourier Analysis
Humans
Male
Middle Aged
Neurologic Examination / drug effects,  instrumentation
Parkinson Disease, Secondary / chemically induced*,  drug therapy
Propranolol / adverse effects,  therapeutic use*
Schizophrenia / drug therapy*
Schizophrenic Psychology*
Signal Processing, Computer-Assisted / instrumentation
Tremor / chemically induced*,  drug therapy
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deficient repair of DNA lesion O6-methylguanine in cirrhosis.
Next Document:  Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study.